| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8239992 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 8 Pages |
Abstract
The results of our study have shown that 48 Gy in four fractions within 1 week is a safe and effective treatment for peripherally located, Stage IA non-small-cell lung cancer. A steep dose-response curve between 40 and 48 Gy using a daily dose of 12 Gy delivered within 1 week was identified for Stage IB non-small-cell lung cancer in stereotactic body radiotherapy using real-time tumor tracking radiotherapy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Rikiya M.D., Ph.D., Masaharu M.D., Koichi M.D., Ph.D., Yuya M.D., Ph.D., Hiroshi M.D., Norio M.D., Fumihiro M.D., Ph.D., Satoshi M.D., Ph.D., Masaharu M.D., Ph.D., Hiroki M.D., Ph.D.,